scispace - formally typeset
D

Dori R. Germolec

Researcher at National Institutes of Health

Publications -  206
Citations -  11721

Dori R. Germolec is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Immune system & Immunotoxicology. The author has an hindex of 54, co-authored 202 publications receiving 10669 citations. Previous affiliations of Dori R. Germolec include International Agency for Research on Cancer & Research Triangle Park.

Papers
More filters
Journal ArticleDOI

Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells.

TL;DR: It is suggested that trivalent methylated arsenicals, intermediary products of arsenic methylation, may significantly contribute to the adverse effects associated with exposure to iAs, and high methylation capacity does not protect cells from the acute toxicity of triavalent arsenicals.
Journal ArticleDOI

Immunotoxicity of Perfluorinated Compounds: Recent Developments

TL;DR: Current and recently published work exploring immunomodulation by PFOA, PFOS, and other PFCs in rodent models, alternative laboratory models, and wildlife suggest that immune effects in laboratory animal models occur at serum concentrations below, within the reported range, or just above those reported for highly exposed humans and wildlife.
Journal ArticleDOI

Evaluation of nanoparticle immunotoxicity

TL;DR: Practical strategies for identifying and controlling interferences in common evaluation methods and the implications for regulation are outlined.